Search

Author/Creator Leverson, Joel D.

2. Clearance of systemic hematologic tumors by venetoclax (Abt‐199) and navitoclax. Issue 5 (1st September 2015)

Authors:
Ackler, Scott; Oleksijew, Anatol; Chen, Jun; Chyla, Brenda J.; Clarin, Jerry; Foster, Kelly; McGonigal, Thomas; Mishra, Sasmita; Schlessinger, Sally; Smith, Morey L.; Tahir, Stephen K.; Leverson, Joel D.; Souers, Andrew J.; Boghaert, Erwin R.; Hickson, Jonathan
Journal:
Pharmacology research & perspectives
Issue:
Volume 3:Issue 5(2015:Oct)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Clearance of therapy‐induced senescent tumor cells by the senolytic ABT‐263 via interference with BCL‐XL–BAX interaction. Issue 10 (5th August 2020)

Authors:
Saleh, Tareq; Carpenter, Valerie J.; Tyutyunyk‐Massey, Liliya; Murray, Graeme; Leverson, Joel D.; Souers, Andrew J.; Alotaibi, Moureq R.; Faber, Anthony C.; Reed, Jason; Harada, Hisashi; Gewirtz, David A.
Journal:
Molecular oncology
Issue:
Volume 14:Issue 10(2020)
Page Start:
2504
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Identification of recurrent genomic alterations in the apoptotic machinery in chronic lymphocytic leukemia patients treated with venetoclax monotherapy. Issue 2 (24th November 2021)

Authors:
Popovic, Relja; Dunbar, Fengjiao; Lu, Charles; Robinson, Kenneth; Quarless, Danjuma; Warder, Scott E.; Mukherjee, Nabanita; Pesko, John; Souers, Andrew J.; Waring, Jeffrey F.; Davids, Matthew S.; Tausch, Eugen; Stilgenbauer, Stephan; Ross, Jeremy A.; Leverson, Joel D.; Kim, Su Young; Chyla, Brend...
Journal:
American journal of hematology
Issue:
Volume 97:Issue 2(2022)
Page Start:
E47
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗